Thymosin alpha-1
Thymalfasin / Tα1 / Talpha1
- Peptide length
- 28 amino acids
N-acetylated peptide
Open the sources to check how the studies were done and what they can support.
An immunomodulatory peptide with human research in several disease settings, including sepsis.
- Family
- Thymic peptide
- Research target
- Immune modulation
- Molecular form
- N-acetylated peptide
What to know about the research
The larger TESTS trial found no clear reduction in 28-day mortality in adults with sepsis. Earlier immune-marker changes and subgroup signals do not establish a general survival benefit.
Check the exact compound
Thymosin alpha-1, thymosin beta-4 and thymic extracts are not interchangeable despite their related names.
What supports this entry?
The reference list is available. A statement-by-statement source check has not been completed for this entry.
These are selected references, not a complete review of the literature. Source checks were assisted by AI and have not received independent expert review.
Research stage, study quality and regulatory status answer different questions. A study card does not establish treatment benefit or approval.
No study details have been extracted for this exact entry yet. This does not mean that no studies exist. Open the references and check the exact material.
How we prepare and correct these entries